Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY4066434 |
Synonyms | |
Therapy Description |
LLY4066434 is a pan-KRAS inhibitor, which potentially decreases growth of tumors harboring KRAS mutations (Cancer Res (2025) 85 (8_Supplement_1): 4375). |